Connection
Tamir Kanias to Hormone Replacement Therapy
This is a "connection" page, showing publications Tamir Kanias has written about Hormone Replacement Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.079 |
|
|
|
-
Hazegh K, Bravo MD, Kamel H, Dumont L, Kanias T. The prevalence and demographic determinants of blood donors receiving testosterone replacement therapy at a large USA blood service organization. Transfusion. 2020 05; 60(5):947-954.
Score: 0.576
-
Chitrakar A, Bean SM, Kanias T, Thomas KA. Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy. Transfusion. 2024 08; 64(8):1520-1532.
Score: 0.194
-
Hazegh K, Anawalt BD, Dumont LJ, Kanias T. Toxic masculinity in red blood cell units? Testosterone therapy in blood donors revisited. Transfusion. 2021 11; 61(11):3174-3180.
Score: 0.160
-
Alexander K, Hazegh K, Fang F, Sinchar D, Kiss JE, Page GP, D'Alessandro A, Kanias T. Testosterone replacement therapy in blood donors modulates erythrocyte metabolism and susceptibility to hemolysis in cold storage. Transfusion. 2021 01; 61(1):108-123.
Score: 0.150